Paper21998583
Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
Smith DS and 7 others. PLoS Pathog, 2011. Cited by 33 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. Papers, record 21998583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21998583
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| Antibody Formation | Major topic |
| Cytidine Deaminase | Major topic |
| Friend murine leukemia virus | Major topic |
| Virion | Major topic |
| Animals | |
| Antiviral Agents | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Knockout | |
| Phenotype | |
| Plasma | |
| Promoter Regions, Genetic | |
| RNA, Viral | |
| Reverse Transcription | |
| Sequence Analysis, RNA | |
| Viral Load |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AI027763 | NIAID NIH HHS | United States | P30AI027763 | PubMed and NIH | NIH RePORTER |
| R01 AI090795 | NIAID NIH HHS | United States | R01AI090795 | PubMed and NIH | NIH RePORTER |
| R56 AI084123 | NIAID NIH HHS | United States | R56AI084123 | PubMed and NIH | NIH RePORTER |
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| ZIAAI000753 | NIH | NIH RePORTER | |||
| ZIAAI001103 | NIH | NIH RePORTER |
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,670,036 | HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. | J Exp Med | 1998 | https://conductscience.org/library/papers/9670036 | PubMed |
| 2 | 20,980,520 | Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. | J Virol | 2011 | https://conductscience.org/library/papers/20980520 | PubMed |
| 3 | 15,297,622 | Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15297622 | PubMed |
| 4 | 12,859,895 | Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. | Cell | 2003 | https://conductscience.org/library/papers/12859895 | PubMed |
| 5 | 14,528,301 | HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. | Nat Med | 2003 | https://conductscience.org/library/papers/14528301 | PubMed |
| 6 | 16,103,203 | APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. | J Virol | 2005 | https://conductscience.org/library/papers/16103203 | PubMed |
| 7 | 15,098,018 | Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. | Nat Struct Mol Biol | 2004 | https://conductscience.org/library/papers/15098018 | PubMed |
| 8 | 20,457,926 | Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20457926 | PubMed |
| 9 | 12,167,863 | Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. | Nature | 2002 | https://conductscience.org/library/papers/12167863 | PubMed |
| 10 | 15,650,227 | G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. | J Virol | 2005 | https://conductscience.org/library/papers/15650227 | PubMed |
| 11 | 14,527,406 | HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. | Mol Cell | 2003 | https://conductscience.org/library/papers/14527406 | PubMed |
| 12 | 18,598,197 | Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. | J Infect Dis | 2008 | https://conductscience.org/library/papers/18598197 | PubMed |
| 13 | 19,153,233 | Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection. | J Virol | 2009 | https://conductscience.org/library/papers/19153233 | PubMed |
| 14 | 20,375,169 | Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. | J Virol | 2010 | https://conductscience.org/library/papers/20375169 | PubMed |
| 15 | 19,027,134 | Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome. | Virology | 2009 | https://conductscience.org/library/papers/19027134 | PubMed |
| 16 | 14,528,300 | The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. | Nat Med | 2003 | https://conductscience.org/library/papers/14528300 | PubMed |
| 17 | 6,833,759 | Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia. | J Immunol | 1983 | https://conductscience.org/library/papers/6833759 | PubMed |
| 18 | 7,518,532 | Characterization of epitopes defining two major subclasses of polytropic murine leukemia viruses (MuLVs) which are differentially expressed in mice infected with different ecotropic MuLVs. | J Virol | 1994 | https://conductscience.org/library/papers/7518532 | PubMed |
| 19 | 20,566,830 | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | J Immunol | 2010 | https://conductscience.org/library/papers/20566830 | PubMed |
| 20 | 12,163,607 | Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. | J Virol | 2002 | https://conductscience.org/library/papers/12163607 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,856,651 | Reduced vacuolar ATPase protects mice from Friend virus infection - an unintended but instructive effect in Hif-2afl mice. | J Cell Sci | 2024 | https://conductscience.org/library/papers/38856651 | PubMed |
| 34,893,529 | SAMHD1 Promotes the Antiretroviral Adaptive Immune Response in Mice Exposed to Lipopolysaccharide. | J Immunol | 2022 | https://conductscience.org/library/papers/34893529 | PubMed |
| 33,121,095 | Mouse APOBEC3 Restriction of Retroviruses. | Viruses | 2020 | https://conductscience.org/library/papers/33121095 | PubMed |
| 32,051,266 | Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease. | J Virol | 2020 | https://conductscience.org/library/papers/32051266 | PubMed |
| 31,087,035 | Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity. | FEMS Microbiol Rev | 2019 | https://conductscience.org/library/papers/31087035 | PubMed |
| 30,782,653 | Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral Persistence. | mBio | 2019 | https://conductscience.org/library/papers/30782653 | PubMed |
| 30,574,147 | Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1. | Front Immunol | 2018 | https://conductscience.org/library/papers/30574147 | PubMed |
| 28,415,995 | Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction. | Retrovirology | 2017 | https://conductscience.org/library/papers/28415995 | PubMed |
| 27,880,772 | T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses. | PLoS One | 2016 | https://conductscience.org/library/papers/27880772 | PubMed |
| 27,477,283 | Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1. | Cell Rep | 2016 | https://conductscience.org/library/papers/27477283 | PubMed |
| 26,957,198 | Tetherin/BST-2: Restriction Factor or Immunomodulator? | Curr HIV Res | 2016 | https://conductscience.org/library/papers/26957198 | PubMed |
| 26,846,717 | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | Sci Rep | 2016 | https://conductscience.org/library/papers/26846717 | PubMed |
| 26,529,416 | Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/26529416 | PubMed |
| 25,994,147 | Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques. | Immunogenetics | 2015 | https://conductscience.org/library/papers/25994147 | PubMed |
| 25,818,029 | APOBECs and virus restriction. | Virology | 2015 | https://conductscience.org/library/papers/25818029 | PubMed |
| 25,589,647 | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | J Virol | 2015 | https://conductscience.org/library/papers/25589647 | PubMed |
| 25,539,593 | Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. | Retrovirology | 2014 | https://conductscience.org/library/papers/25539593 | PubMed |
| 25,501,566 | APOBEC3 enzymes restrict marginal zone B cells. | Eur J Immunol | 2015 | https://conductscience.org/library/papers/25501566 | PubMed |
| 25,303,118 | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | Virology | 2014 | https://conductscience.org/library/papers/25303118 | PubMed |
| 24,872,193 | Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo. | J Immunol | 2014 | https://conductscience.org/library/papers/24872193 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOBEC3G | 60,489 | PubTator's text mining | https://conductscience.org/library/genes/60489 | NCBI Gene |
| BST2 | 684 | PubTator's text mining | https://conductscience.org/library/genes/684 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CDA | 978 | PubTator's text mining | https://conductscience.org/library/genes/978 | NCBI Gene |
| F5 | 2,153 | PubTator's text mining | https://conductscience.org/library/genes/2153 | NCBI Gene |
| IFNA1 | 3,439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| POTEF | 728,378 | PubTator's text mining | https://conductscience.org/library/genes/728378 | NCBI Gene |
| SAMHD1 | 25,939 | PubTator's text mining | https://conductscience.org/library/genes/25939 | NCBI Gene |
| TRIM5 | 85,363 | PubTator's text mining | https://conductscience.org/library/genes/85363 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21998583
GET https://conductscience.org/api/papers/v1/21998583/references?page=2